Chao Fang
Chao Fang
1Departments of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008 P. R. China
2Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, 410078 P. R. China
1,2,
Yi-Xin Chen
Yi-Xin Chen
1Departments of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008 P. R. China
2Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, 410078 P. R. China
1,2,
Na-Yiyuan Wu
Na-Yiyuan Wu
1Departments of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008 P. R. China
2Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, 410078 P. R. China
1,2,
Ji-Ye Yin
Ji-Ye Yin
1Departments of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008 P. R. China
2Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, 410078 P. R. China
1,2,
Xiang-Ping Li
Xiang-Ping Li
3Departments of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008 P. R. China
3,
Hsuan-Shun Huang
Hsuan-Shun Huang
4Department of Research, Cervical Cancer Prevention Center, Tzu Chi University, Hualien, 970 Taiwan, Republic of China
4,
Wei Zhang
Wei Zhang
1Departments of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008 P. R. China
2Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, 410078 P. R. China
1,2,
Hong-Hao Zhou
Hong-Hao Zhou
1Departments of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008 P. R. China
2Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, 410078 P. R. China
5Hunan Province Cooperation Innovation Center for Molecular Target New Drug Study, Hengyang, 421001 P. R. China
1,2,5,
Zhao-Qian Liu
Zhao-Qian Liu
1Departments of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008 P. R. China
2Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, 410078 P. R. China
5Hunan Province Cooperation Innovation Center for Molecular Target New Drug Study, Hengyang, 421001 P. R. China
1,2,5,✉
1Departments of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008 P. R. China
2Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, 410078 P. R. China
3Departments of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008 P. R. China
4Department of Research, Cervical Cancer Prevention Center, Tzu Chi University, Hualien, 970 Taiwan, Republic of China
5Hunan Province Cooperation Innovation Center for Molecular Target New Drug Study, Hengyang, 421001 P. R. China
© The Author(s) 2021
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
